Oncology Recommendations for Second-Generation Tyrosine Kinase Inhibitors As Frontline Therapy in the Management of Chronic Myeloid Leukemia patient care perspectives By Mark J. Levis, MD, PhD
Oncology Multiple Myeloma: Immunomodulatory Agents in the Evolving Treatment Paradigm patient care perspectives By Kenneth C. Anderson, MD
Oncology Safety and Tolerability of Long-Term, Continuous Treatment for Multiple Myeloma patient care perspectives By Sagar Lonial, MD, FACP
Oncology Precision Therapies for Non–Small Cell Lung Cancer: Side Effects and Patient Education patient care perspectives By Jeffrey Crawford, MD
Dermatology Obesity and Metabolic Health in Patients With Psoriasis patient care perspectives By Joel M. Gelfand, MD, MSCE